GH
Gwenn Hansen sold $37K of NRIX stock
Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 1,452 shares of NRIX stock worth $37K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Sep 1, 2026.
NRIX has moved -45.9% since the trade date, from $26.04 to $14.10 (Nov 18, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 0 days
- Price since
- -45.9%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4